Any Malignant Brain Tumor
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Any Malignant Brain Tumor
Search results are returned below separately for clinical trials, frequently asked questions, pages on this site, and news articles - scroll down to see them all!

Trials and Noteworthy Treatments

  Treatment Next 25 Location Last Updated
Details Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor (Toca 511) Los Angeles, CA
Detroit, MI
Edison, NJ
Columbus, OH
Seattle, WA
02/01/2012
Details Molecular Biology of Central Nervous System (CNS) Tumors Houston, TX 12/20/2010
Details A Phase I Study of MK-0752, a Notch Inhibitor, in Patients With Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors San Francisco, CA 04/12/2010
Details Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma San Francisco, CA 01/11/2010
Details ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients with Malignant Glioma San Francisco, CA 07/07/2009
Details A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors Bethesda, MD 04/22/2009
Details Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors. Bethesda, MD 04/22/2009
Details Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection Santa Monica, CA 11/29/2008
Details Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors Charlottesville, VA 09/30/2008
Details High dose erlotinib for recurrent/residual GBM; Correlation of response to EGFRvIII and PTEN status New York, NY 11/08/2007
Details A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors NEW YORK CITY, NY 08/20/2007
Details A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy Copenhagen, Denmark 08/18/2007
Details Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. Los Angeles, CA
Durham, NC
08/18/2007
Details The use of the Gliasite radiation therapy system for malignant gliomas Philadelphi, PA 08/18/2007
Details Brain Mapping for Brain Tumors Boston, MA 08/18/2007
Details Functional image guided removal of brain tumors Manhasset, NY 08/18/2007
Details Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma Detroit, MI 05/01/2007
Details Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors Birmingham, AL
Scottsdale/Phoenix, AZ
Jacksonville, FL
Cedar Rapids, IA
Des Moines, IA
Missouri Valley, IA
Sioux City, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Rochester, MN
Saint Cloud, MN
Bismarck, ND
Fargo, ND
Lincoln, NE
Allentown, PA
06/26/2006
Details Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors Los Angeles, CA 05/29/2006
Details Phase II trial of Temodar ® plus O6-Benzylguanine in the treatment of patients with Temodar® -resistant malignant glioma. Durham, NC 12/03/2005
Details Pharmacological intervention for learning impaired children surviving treatment for cancer. Durham, NC 12/03/2005
Details Gamma Knife Radiosurgery Smithtown, NY 12/03/2005
Details Gamma Knife Radiosurgery for Brain Tumors La Jolla, CA 12/03/2005
Details Phase I trial of Temodar plus O6-Benzylguanine plus Irinotecan (CPT-11) in the treatment of patients with recurrent/progressive Cerebral anaplastic gliomas. Durham, NC 12/03/2005
Details Phase I trial of Temozolomide (Temodar) and O6-Benzylguanine (o6-bg)in pediatric patients with recurrent brain tumors. Durham, NC 12/03/2005


News Stories



Frequently Asked Questions







Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2012 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites